Dimensional Fund Advisors
EWTX icon

Dimensional Fund Advisors’s Edgewise Therapeutics EWTX Stock Holding History

Dimensional Fund Advisors’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$38.4M Buy
1,219,717
+6,060
+0.5% +$175K 0.01% 1647
2025
Q4 		$30.1M Buy
1,213,657
+30,521
+3% +$613K 0.01% 1773
2025
Q3 		$19.2M Buy
1,183,136
+134,200
+13% +$1.9M ﹤0.01% 2006
2025
Q2 		$13.8M Buy
1,048,936
+381,437
+57% +$5.5M ﹤0.01% 2141
2025
Q1 		$14.7M Sell
667,499
-62,424
-9% -$1.64M ﹤0.01% 2085
2024
Q4 		$19.5M Buy
729,923
+3,052
+0.4% +$97.2K ﹤0.01% 2003
2024
Q3 		$19.4M Buy
726,871
+259,364
+55% +$5.16M ﹤0.01% 2018
2024
Q2 		$8.42M Buy
467,507
+168,219
+56% +$2.93M ﹤0.01% 2331
2024
Q1 		$5.46M Buy
299,288
+37,050
+14% +$589K ﹤0.01% 2526
2023
Q4 		$2.87M Buy
262,238
+87,317
+50% +$613K ﹤0.01% 2706
2023
Q3 		$1M Buy
174,921
+101,863
+139% +$692K ﹤0.01% 2927
2023
Q2 		$566K Buy
73,058
+45,775
+168% +$386K ﹤0.01% 3038
2023
Q1 		$182K Buy
27,283
+1,091
+4% +$10.1K ﹤0.01% 3221
2022
Q4 		$235 Buy
26,192
+12
+0% +$112 ﹤0.01% 3196
2022
Q3 		$258K Buy
+26,180
New +$265K ﹤0.01% 3194

Other funds holding EWTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Dimensional Fund Advisors's EWTX Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Edgewise Therapeutics (EWTX) stake by 0.5% in Q1 2026, buying an estimated $175K and bringing the position to 1,219,717 shares worth $38.4M. The position accounts for 0.01% of the portfolio, ranked #1647.

Dimensional Fund Advisors first reported a position in EWTX in Q3 2022 and has held it in 15 quarters since. 214 funds tracked by Wall St. Rank hold EWTX as of Q1 2026.

  • Dimensional Fund Advisors held 1,219,717 shares of Edgewise Therapeutics worth $38.4M as of Q1 2026.
  • Dimensional Fund Advisors bought 6,060 Edgewise Therapeutics shares in Q1 2026, an estimated $175K.
  • Edgewise Therapeutics made up 0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #1647 holding.
  • Dimensional Fund Advisors first reported a position in Edgewise Therapeutics in Q3 2022 and has held it in 15 quarters since.
  • 214 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.